Viewing Study NCT06709495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2025-12-28 @ 6:09 AM
Study NCT ID: NCT06709495
Status: RECRUITING
Last Update Posted: 2025-02-13
First Post: 2024-11-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Sponsor: David S Shulman, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma View
None Sarcoma, Ewing View
None Desmoplastic Small Round Cell Tumor View
None Refractory Sarcoma View
None Osteosarcoma View
None Rhabdomyosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sarcoma View
None Sarcoma, Ewing View
None Desmoplastic Small Round Cell Tumor View
None Refractory Sarcoma View
None Relapsed Sarcoma View
None osteosarcoma View
None rhabdomyosarcoma View